Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dose Dense Chemotherapy + Rituximab for High-Risk Diffuse Large B-Cell Lymphoma
NCT00499018Phase 3Unknown
- Sponsor
- Fondazione Italiana Linfomi
- Start
- Jan 2006
- Primary completion
- Jun 2011
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 3 trial of cyclophosphamide, doxorubicin, mitoxantrone, cytarabine, carmustine in diffuse large B-cell lymphoma (DLBCL), follicular lymphoma (FL), sponsored by Fondazione Italiana Linfomi. Status: unknown.
02
Drugs
cyclophosphamidedoxorubicinmitoxantronecytarabinecarmustine
03
Conditions
diffuse large B-cell lymphoma (DLBCL)follicular lymphoma (FL)
Beyond the preview
Go deeper on NCT00499018.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00499018.